Physician profile
Fi Dan Lo
NPI 1457813974
$761.70
in general payments reported to CMS, 2019-2025
15 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.87 · 2023: $213 · 2024: $118 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $153.95 | 2023-2025 | Mounjaro, Trulicity, Zepbound |
| Merck Sharp & Dohme LLC | $118.76 | 2022-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Dynavax Technologies Corporation | $97.74 | 2025 | Heplisav-B |
| Glaxosmithkline, LLC. | $73.85 | 2023-2024 | Shingrix, Bexsero |
| Novo Nordisk INC | $65.16 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $39.91 | 2025 | The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.06 | 2022-2023 | Jardiance |
| Amgen INC. | $30.83 | 2023 | Otezla, Repatha |
| Hologic Sales and Service, LLC | $25.71 | 2025 | Aptima |
| Corcept Therapeutics | $24.11 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $23.13 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $22.05 | 2025 | Libtayo |
| Medtronic, INC. | $21.22 | 2025 | Minimed 780g |
| Shield Therapeutics INC | $19.87 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fi Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.